A common statement from Health Civil Society on the EU regulation of pharmaceuticals: The patients, healthcare users, and public health organisations we represent are extremely concerned about the progress of negotiations in the European Parliament on the...
By Síofra Kelleher A lot of people would assume I would remember the day I was diagnosed with Type One Diabetes like it was yesterday, but to be honest, I don’t. I remember the feeling. Type One Diabetes has four main symptoms, abbreviated to TEST. Thirst, Energy...
6th EPHA Universal Access and Affordable Medicines Forum 8 December 2023 09:30 - 13:00 Scotland House Brussels Rdpt Robert Schuman 6, 1040 Brussels, Belgium The Access to Medicines (A2M) Forum, hosted annually by EPHA, serves as a platform for facilitating...
EPHA welcomes the opportunity to provide feedback on the European Commission’s proposed pharmaceutical package (proposed Regulation and Directive). The proposed pharmaceutical package is a very positive step towards addressing unequal access to medicines across the...
Guest article by Catherine Hartmann, EPHA’s Scientific Advisor on Brussels Advocacy and former Executive Director of the European Blood Alliance (EBA) Next week, EU decision-makers will make choices regarding Substances of Human Origin (SoHO) that will tie the...
